Your browser doesn't support javascript.
Transplanting thoracic COVID-19 positive donors: An institutional protocol and report of the first 14 cases.
Eichenberger, Emily M; Coniglio, Amanda C; Milano, Carmelo; Schroder, Jacob; Bryner, Benjamin S; Spencer, Philip J; Haney, John C; Klapper, Jacob; Glass, Carolyn; Pavlisko, Elizabeth; Dibernardo, Louis; Patel, Chetan B; DeVore, Adam D; Reynolds, John; Wolfe, Cameron R.
  • Eichenberger EM; Division of Transplant Infectious Diseases, Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA.
  • Coniglio AC; Division of Transplant Cardiology, Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA.
  • Milano C; Division of Cardiothoracic Surgery, Department of Surgery, Duke University Medical Center, Durham, North Carolina, USA.
  • Schroder J; Division of Cardiothoracic Surgery, Department of Surgery, Duke University Medical Center, Durham, North Carolina, USA.
  • Bryner BS; Division of Cardiothoracic Surgery, Department of Surgery, Duke University Medical Center, Durham, North Carolina, USA.
  • Spencer PJ; Division of Cardiothoracic Surgery, Department of Surgery, Duke University Medical Center, Durham, North Carolina, USA.
  • Haney JC; Division of Cardiothoracic Surgery, Department of Surgery, Duke University Medical Center, Durham, North Carolina, USA.
  • Klapper J; Division of Cardiothoracic Surgery, Department of Surgery, Duke University Medical Center, Durham, North Carolina, USA.
  • Glass C; Department of Pathology, Duke University Medical Center, Durham, North Carolina, USA.
  • Pavlisko E; Department of Pathology, Duke University Medical Center, Durham, North Carolina, USA.
  • Dibernardo L; Department of Pathology, Duke University Medical Center, Durham, North Carolina, USA.
  • Patel CB; Division of Transplant Cardiology, Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA.
  • DeVore AD; Division of Transplant Cardiology, Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA.
  • Reynolds J; Division of Transplant Pulmonology, Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA.
  • Wolfe CR; Division of Transplant Infectious Diseases, Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA. Electronic address: cw74@duke.edu.
J Heart Lung Transplant ; 41(10): 1376-1381, 2022 10.
Article in English | MEDLINE | ID: covidwho-1914428
ABSTRACT
We present our institution's protocol for evaluating and transplanting thoracic organs from COVID-19 positive donors and report the outcomes to date. Hearts from donors testing positive for COVID-19 on any test were eligible for transplantation at our institution provided the donor exhibited no evidence of hypercoagulability or COVID-19 induced hyperinflammatory state during terminal hospitalization. Lungs were eligible if the donor first tested PCR positive on nasopharyngeal swab (NPS) for COVID-19 > 20 days prior to procurement and had a negative lower respiratory tract specimen. We performed 14 thoracic transplants in 13 recipients using organs from COVID-19 positive donors. None of the recipients or healthcare members acquired COVID-19. No recipients suffered unexpected acute rejection. Patient survival is 92% to date, with graft survival 93%. The use of hearts from COVID-19 positive donors may be safe and effective. Transplantation of lungs is unresolved but may be cautiously pursued under the restricted circumstances.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Tissue and Organ Procurement / Lung Transplantation / COVID-19 Type of study: Experimental Studies / Prognostic study Limits: Humans Language: English Journal: J Heart Lung Transplant Journal subject: Cardiology / Transplantation Year: 2022 Document Type: Article Affiliation country: J.healun.2022.06.018

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Tissue and Organ Procurement / Lung Transplantation / COVID-19 Type of study: Experimental Studies / Prognostic study Limits: Humans Language: English Journal: J Heart Lung Transplant Journal subject: Cardiology / Transplantation Year: 2022 Document Type: Article Affiliation country: J.healun.2022.06.018